| Publication |
Sentence |
Publish Date |
Extraction Date |
Species |
| Charles Massie, Frédérique Dubé, Soumaya Sridi-Cheniti, Julien Ternacle, Stéphane Lafitte, Patricia Réan. Characterization of left atrial strain in left ventricular hypertrophy: A study of Fabry disease, sarcomeric hypertrophic cardiomyopathy and cardiac amyloidosis. Archives of cardiovascular diseases. 2025-03-11. PMID:40069068. |
characterization of left atrial strain in left ventricular hypertrophy: a study of fabry disease, sarcomeric hypertrophic cardiomyopathy and cardiac amyloidosis. |
2025-03-11 |
2025-03-14 |
Not clear |
| Natsuko Inagaki, Yasuyoshi Takei, Tsuguhisa Hatano, Yasuyuki Takada, Yoshinao Yazaki, Hisanori Kosuge, Masatake Kobayashi, Shinji Suzuki, Tomohiro Umezu, Masahiko Kuroda, Kazuhiro Satomi, Takeharu Hayash. Clinical characteristics of female Fabry disease patients with hypertrophic cardiomyopathy with mid-ventricular obstruction. Molecular genetics and metabolism reports. vol 42. 2025-02-25. PMID:39995634. |
clinical characteristics of female fabry disease patients with hypertrophic cardiomyopathy with mid-ventricular obstruction. |
2025-02-25 |
2025-02-27 |
Not clear |
| Maurizio Pieroni, Chiara Zocchi, Michele Ciabatt. Cardiac involvement in Fabry disease: Recent advances, unresolved issues, and unmet needs. European heart journal supplements : journal of the European Society of Cardiology. vol 27. issue Suppl 1. 2025-02-21. PMID:39980776. |
cardiac involvement is a prominent feature and a major cause of morbidity and mortality in fabry disease, manifesting as left ventricular hypertrophy, myocardial ischaemia, heart failure, and arrhythmias. |
2025-02-21 |
2025-02-23 |
Not clear |
| Jiaqi Li, Meiling Chang, Zeyuan Mei, Qing Zhu, Xin Yue, Mei Zhang, Mengmeng Li, Xiaoling Li. Female Fabry Patient With Left Ventricular Outflow Tract Obstruction. JACC. Case reports. vol 30. issue 4. 2025-02-20. PMID:39972695. |
cardiac involvement in fabry disease is usually characterized by left ventricular hypertrophy (lvh) without obstruction at rest. |
2025-02-20 |
2025-02-23 |
Not clear |
| Jing-Xiu Li, Xin-Xin Di, Min Gao, Xue-Qi Li, Yan-Lin Wang, Jie Zhen. Chest Discomfort, Left Ventricular Hypertrophy, Global T-Wave Inversion, and Short PR Interval Points to a Particular Cardiac Condition. What Could Be the Diagnosis? Annals of noninvasive electrocardiology : the official journal of the International Society for Holter and Noninvasive Electrocardiology, Inc. vol 30. issue 2. 2025-02-07. PMID:39916668. |
short pr interval with left ventricular hypertrophy (lvh) poses a diagnostic challenge, requiring advanced imaging and genetic testing to differentiate fabry disease from other cardiomyopathies. |
2025-02-07 |
2025-02-09 |
Not clear |
| Y K Liu, Q P Shi, X Y Luo, W M. [Hypertrophic obstructive cardiomyopathy associated with Fabry disease: a case report]. Zhonghua nei ke za zhi. vol 64. issue 2. 2025-01-25. PMID:39863564. |
[hypertrophic obstructive cardiomyopathy associated with fabry disease: a case report]. |
2025-01-25 |
2025-01-28 |
Not clear |
| Huixi Ma, Yun Wang, Yang Jia, Linjun Xie, Lini Liu, Dingyi Zhang, Xinyue Ma, Yingkun Guo, Rong X. Advances in genetic diagnosis and therapy of hereditary heart disease: a bibliometric review from 2004 to 2024. Frontiers in medicine. vol 11. 2025-01-23. PMID:39845823. |
hypertrophic cardiomyopathy (hcm), arrhythmogenic cardiomyopathy (acm), brugada syndrome (brs), myocardial amyloidosis, and fabry disease (fd) were the main types of hhd that were explored in greater depth. |
2025-01-23 |
2025-01-25 |
Not clear |
| Kolja Lau, Victoria Sokalski, Lora Lorenz, Georg Fette, Claudia Sommer, Nurcan Üçeyler, Christoph Wanner, Peter Nordbec. Automated electronic health record-based screening for Fabry disease in unexplained left ventricular hypertrophy (FAPREV-HCM). Open heart. vol 12. issue 1. 2025-01-12. PMID:39800432. |
automated electronic health record-based screening for fabry disease in unexplained left ventricular hypertrophy (faprev-hcm). |
2025-01-12 |
2025-01-16 |
Not clear |
| Kolja Lau, Victoria Sokalski, Lora Lorenz, Georg Fette, Claudia Sommer, Nurcan Üçeyler, Christoph Wanner, Peter Nordbec. Automated electronic health record-based screening for Fabry disease in unexplained left ventricular hypertrophy (FAPREV-HCM). Open heart. vol 12. issue 1. 2025-01-12. PMID:39800432. |
hypertrophic cardiomyopathy (hcm) has various aetiologies, including genetic conditions like fabry disease (fd), a lysosomal storage disorder. |
2025-01-12 |
2025-01-16 |
Not clear |
| Francesca Giovannetti, Mattia D'Andrea, Federico Bracci, Andrea Frustaci, Cristina Chimenti, Pietro Mangiantini, Alessandro Lambiase, Marco Marenc. Anderson-Fabry Disease: Focus on Ophthalmological Implications. Life (Basel, Switzerland). vol 14. issue 12. 2025-01-08. PMID:39768240. |
fabry disease (fd) is a rare x-linked lysosomal storage disorder with a broad spectrum of clinical manifestations, including severe complications, such as end-stage renal disease, hypertrophic cardiomyopathy, and cerebrovascular disease. |
2025-01-08 |
2025-01-13 |
Not clear |
| Maarten A Van Diepen, Manou Speleman, Lourens F H J Robbers, Maarten Groenink, Adrienne van Randen, Mirjam Langeveld, Saskia N Van der Crabben, Nick R Bijsterveld, Harald T Jørsta. Inferolateral Fibrosis in a Nonhypertrophic Left Ventricle. JACC. Case reports. vol 29. issue 22. 2024-12-18. PMID:39691882. |
despite absence of left ventricular hypertrophy, multidisciplinary evaluation and a positive family history led to the diagnosis of non-classical fabry disease. |
2024-12-18 |
2024-12-21 |
Not clear |
| Weili Cheng, Mingqiang Ao, Dinghu Xu, Yuqing Zhang, Qin Ta. Case Report: Diagnostic challenges in Fabry disease: misinterpreted obstructive hypertrophic cardiomyopathy and the role of enzyme replacement therapy. Frontiers in cardiovascular medicine. vol 11. 2024-12-09. PMID:39650153. |
case report: diagnostic challenges in fabry disease: misinterpreted obstructive hypertrophic cardiomyopathy and the role of enzyme replacement therapy. |
2024-12-09 |
2024-12-12 |
Not clear |
| Jialin Li, Lutong Pu, Ziqian Xu, Ke Wan, Yuanwei Xu, Jie Wang, Yuchi Han, Yucheng Che. Screening for Fabry disease in patients with hypertrophic cardiomyopathy using cardiac magnetic resonance imaging. European radiology. 2024-11-19. PMID:39562366. |
screening for fabry disease in patients with hypertrophic cardiomyopathy using cardiac magnetic resonance imaging. |
2024-11-19 |
2024-11-23 |
Not clear |
| Jialin Li, Lutong Pu, Ziqian Xu, Ke Wan, Yuanwei Xu, Jie Wang, Yuchi Han, Yucheng Che. Screening for Fabry disease in patients with hypertrophic cardiomyopathy using cardiac magnetic resonance imaging. European radiology. 2024-11-19. PMID:39562366. |
fabry disease (fd) usually mimics hypertrophic cardiomyopathy (hcm). |
2024-11-19 |
2024-11-23 |
Not clear |
| Alexios S Antonopoulos, Theodoros Tsampras, George Lazaros, Konstantinos Tsioufis, Charalambos Vlachopoulo. A phenomap of TTR amyloidosis to aid diagnostic screening. ESC heart failure. 2024-10-31. PMID:39482264. |
findings that suggest negative markers for attr can point towards other forms of amyloidosis (such as al amyloidosis) or alternate causes of left ventricular hypertrophy, including hypertrophic cardiomyopathy or fabry disease. |
2024-10-31 |
2024-11-03 |
Not clear |
| Constantin Gatterer, Dietrich Beitzke, Gere Sunder-Plassmann, Maximilian Friedl, Philipp Hohensinner, Christopher Mann, Markus Ponleitner, Senta Graf, Max Len. NT-proBNP Reflects Left Ventricular Hypertrophy Rather than Left Ventricular Dilatation or Systolic Dysfunction in Patients with Fabry Disease. Journal of clinical medicine. vol 13. issue 19. 2024-10-16. PMID:39408013. |
nt-probnp reflects left ventricular hypertrophy rather than left ventricular dilatation or systolic dysfunction in patients with fabry disease. |
2024-10-16 |
2024-10-18 |
Not clear |
| Lara Tondi, Giandomenico Disabato, Paolo D'Andria, Andrea Attanasio, Gianluigi Guida, Federico Pieruzzi, Giada De Angeli, Marco Canepa, Gianpaolo Carrafiello, Massimo Piepoli, Pietro Spagnolo, Massimo Lombardi, Antonia Camporeal. Cardiovascular magnetic resonance insights into anomalies of the mitral valve apparatus in Fabry cardiomyopathy and hypertrophic cardiomyopathy. Frontiers in cardiovascular medicine. vol 11. 2024-10-16. PMID:39411176. |
despite different etiopathogenesis, fabry disease cardiomyopathy (fdc) and sarcomeric hypertrophic cardiomyopathy (hcm) share a similar hypertrophic phenotype, including anomalies of the mitral valve apparatus (amva). |
2024-10-16 |
2024-10-18 |
Not clear |
| Zongwei Lin, Xinyu Zhang, Yan Liu, Dongxia Miao, Huanyi Zhang, Tao Zhang, Fenglei Zhang, Peng Li, Hongyan Dai, Guihua Jiang, Dongxia Zhang, Lin Zhong, Huixia Lu, Xiaoping J. Screening for Fabry disease in patients with left ventricular hypertrophy in China: A multicentre and prospective study. ESC heart failure. 2024-09-03. PMID:39225306. |
screening for fabry disease in patients with left ventricular hypertrophy in china: a multicentre and prospective study. |
2024-09-03 |
2024-09-05 |
Not clear |
| Zongwei Lin, Xinyu Zhang, Yan Liu, Dongxia Miao, Huanyi Zhang, Tao Zhang, Fenglei Zhang, Peng Li, Hongyan Dai, Guihua Jiang, Dongxia Zhang, Lin Zhong, Huixia Lu, Xiaoping J. Screening for Fabry disease in patients with left ventricular hypertrophy in China: A multicentre and prospective study. ESC heart failure. 2024-09-03. PMID:39225306. |
left ventricular hypertrophy (lvh) is frequently detected via echocardiography in individuals with fabry disease (fd), sometimes leading to confusion with hypertrophic cardiomyopathy (hcm) of other aetiologies. |
2024-09-03 |
2024-09-05 |
Not clear |
| Ching-Hui Huang, Chen-Ling Kuo, Yu-Shan Cheng, Ching-San Huang, Chin-San Liu, Chia-Chu Chan. Sphingolipid Metabolism Is Associated with Cardiac Dyssynchrony in Patients with Acute Myocardial Infarction. Biomedicines. vol 12. issue 8. 2024-08-29. PMID:39200328. |
cardiac dyssynchrony is observed in patients with fabry disease and left ventricular (lv) hypertrophy. |
2024-08-29 |
2024-09-01 |
Not clear |